Sundaram Preethi
Chief Strategy Officer · 7 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-15 | CPRX | CATALYST PHARMACEUTICALS, INC. | D | 54,804 | $31.50 | $1.7M | filing |
| 2025-12-29 | CPRX | CATALYST PHARMACEUTICALS, INC. | Option exercise | 6,667 | — | — | filing |
| 2025-12-29 | CPRX | CATALYST PHARMACEUTICALS, INC. | Tax withholding | 2,369 | — | — | filing |
| 2025-12-08 | CPRX | CATALYST PHARMACEUTICALS, INC. | Option exercise | 6,855 | — | — | filing |
| 2025-12-08 | CPRX | CATALYST PHARMACEUTICALS, INC. | Tax withholding | 1,669 | — | — | filing |
| 2025-11-21 | CPRX | CATALYST PHARMACEUTICALS, INC. | Option exercise | 5,603 | — | — | filing |
| 2025-11-21 | CPRX | CATALYST PHARMACEUTICALS, INC. | Tax withholding | 1,364 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.